Bio-Inspired Protein-Based Nanoformulations for Cancer Theranostics

Frontiers in Pharmacology
Yi GouGaoxing Su

Abstract

Over the past decade, more interests have been aroused in engineering protein-based nanoformulations for cancer treatment. This excitement originates from the success of FDA approved Abraxane (Albumin-based paclitaxel nanoparticles) in 2005. The new generation of biocompatible endogenous protein-based nanoformulations is currently constructed through delivering cancer therapeutic and diagnostic agents simultaneously, as named potential theranostics. Protein nanoformulations are commonly incorporated with dyes, contrast agents, drug payloads or inorganic nanoclusters, serving as imaging-guided combinatorial cancer therapeutics. Employing the nature identity of proteins, the theranostics, escape the clearance by reticuloendothelial cells and have a long blood circulation time. The nanoscale sizet allows them to be penetrated deeply into tumor tissues. In addition, stimuli release and targeted molecules are incorporated to improve the delivery efficiency. The ongoing advancement of protein-based nanoformulations for cancer theranostics in recent 5 years is reviewed in this paper. Fine-designed nanoformulations based on albumin, ferritin, gelatin, and transferrin are highlighted from the literature. Finally, the current challenges ...Continue Reading

References

Jan 19, 1978·Nature·S H BanyardP M Harrison
Jul 2, 1999·Protein Engineering·S SugioK Kobayashi
Mar 6, 2003·Vox Sanguinis·Jaakko ParkkinenLeila Sahlstedt
Mar 12, 2003·Advanced Drug Delivery Reviews·Jayanth Panyam, Vinod Labhasetwar
Jul 26, 2003·Journal of Controlled Release : Official Journal of the Controlled Release Society·V R Sinha, Aman Trehan
Feb 15, 2005·Drug Discovery Today·Peter T GommeJoseph Bertolini
Sep 10, 2005·American Journal of Respiratory and Critical Care Medicine·Svetlana GelperinaLeonid Heifets
Mar 7, 2006·Nature Reviews. Drug Discovery·Gergely SzakácsMichael M Gottesman
Jul 18, 2006·Current Medicinal Chemistry·Ricardo Pérez-Tomás
Apr 13, 2007·Blood Cells, Molecules & Diseases·Alessia CalzolariUgo Testa
Jul 26, 2008·Nature Nanotechnology·Dan PeerRobert Langer
Jan 6, 2009·Critical Care Medicine·Frédéric PeneJean-Paul Mira
Jul 3, 2009·Small·Aihui MahamYuehe Lin
Oct 30, 2009·Journal of Drug Targeting·Somayeh Hallaj NezhadiCrispin R Dass
Aug 17, 2010·Advanced Drug Delivery Reviews·Siti M JanibJ Andrew MacKay
Dec 15, 2010·Biotechnology Advances·Martin E BrandsmaShengwu Ma
Mar 8, 2011·Cell·Douglas Hanahan, Robert A Weinberg
Mar 25, 2011·Advanced Materials·José A BarretoLeone Spiccia
May 12, 2011·Accounts of Chemical Research·Kenneth K NgGang Zheng
May 27, 2011·Accounts of Chemical Research·Rizia BardhanNaomi J Halas
Jul 5, 2011·Journal of Controlled Release : Official Journal of the Controlled Release Society·Huang-Chiao HuangKaushal Rege
Mar 6, 2012·Chemical Society Reviews·Nazila KamalyOmid C Farokhzad
May 2, 2012·Clinica Chimica Acta; International Journal of Clinical Chemistry·Dominika Szőke, Mauro Panteghini
Jun 9, 2012·Molecular Immunology·Karolina A MajorekWladek Minor
May 28, 2013·Biochimica Et Biophysica Acta·Uttam Anand, Saptarshi Mukherjee
Jun 25, 2013·Expert Opinion on Drug Delivery·Chetan YewaleAmbikanandan Misra
Jul 31, 2013·Biochimica Et Biophysica Acta·Ahmed A Alkhateeb, James R Connor
Sep 21, 2013·Expert Opinion on Drug Delivery·Conchita Tros de Ilarduya, Nejat Düzgüneş
Oct 8, 2013·Journal of Controlled Release : Official Journal of the Controlled Release Society·Ahmed O Elzoghby
Feb 28, 2014·The Journal of Membrane Biology·Stephanie Tortorella, Tom C Karagiannis
Jul 6, 2014·Journal of Controlled Release : Official Journal of the Controlled Release Society·Rishi Paliwal, Srinath Palakurthi
Aug 16, 2014·Advanced Materials·Peng HuangXiaoyuan Chen
Oct 15, 2014·Journal of Controlled Release : Official Journal of the Controlled Release Society·Michela BelliniDavide Prosperi

❮ Previous
Next ❯

Citations

Sep 10, 2019·Expert Opinion on Drug Delivery·Sadia SikderDhananjay Pal
Mar 10, 2020·Chemistry, an Asian Journal·Qianli ZouXuehai Yan
Nov 12, 2019·Frontiers in Pharmacology·Vijay Sagar MadamsettySudip Mukherjee
Aug 13, 2020·Cellular and Molecular Life Sciences : CMLS·Chun YangPierre Hardy
Jul 29, 2020·Cancer Reports·Alastair F BreenTracey D Bradshaw
Oct 23, 2020·Journal of Controlled Release : Official Journal of the Controlled Release Society·Haroon IqbalHuabing Chen
Feb 28, 2021·Scientific Reports·Christian C E LuebbertMichael J W Johnston
Jun 9, 2020·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Elise LepeltierCatherine Passirani
Jun 23, 2020·Annales pharmaceutiques françaises·M ShitoleS Nangare
May 8, 2021·Biomacromolecules·Tianqi NieZhiyu He
Jul 3, 2021·International Journal of Molecular Sciences·Abdulkader BakiRegina Bleul
Aug 8, 2021·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Raluca BorlanSimion Astilean
Aug 28, 2021·Cancers·Paula Milán-RoisÁlvaro Somoza

❮ Previous
Next ❯

Methods Mentioned

BETA
Fluorescence
xenograft
X-ray
fluorescence imaging

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Advances in Protein Chemistry and Structural Biology
Hasan KouchakzadehSeyed Abbas Shojaosadati
Advanced Healthcare Materials
Xiaowen LiuZhuang Liu
© 2022 Meta ULC. All rights reserved